Allied Market Research
Loading...
Cart
0
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Allied Market Research

Immunoassay Interference Blocker Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

A10995
Pages: NA
Jun 2021 | 102 Views
 
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Immunoassay Interference Blocker Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

Request Now !

Substances present in the body such as polyreactive antibodies or heterophiles, or human anti-animal antibodies coupled with some other binding proteins can cause interference due to reactions between analyte and reagent antibodies in immunoassay. These substances have the potential to change the concentration of the analytic or alter antibody binding resulting in immunoassay interference. This alterations can lead to the misinterpretation of the diagnostic outcomes by the laboratory further causing inappropriate selection of course of treatment being given by the healthcare professionals. Interference may cause an impact over a wide range of analytes measured by immunoassay including hormones, tumor markers, drugs, cardiac troponin and microbial serology. Although, the use of interference blockers can reduce the alterations as the interference is low in assays containing blocking agents that neutralize or inhibit the interference.

Immunoassay interference blocker kit consists of reagents that are specifically designed to that neutralize or inhibit the interference and prevent faulty results that enhances the overall assay performance as well.

Market scope and structure analysis:

Report Metric

Details

  Market size available for years

  2019–2027

  Base year considered

  2019

  Forecast period

  2020–2027

  Forecast units

  Value (USD)

  Segments covered

  Products type, Application, End user and Region

  Geographies covered

•             North America (U.S., Canada, Mexico)

•             Europe (France, Germany, UK, Italy, Spain, Rest of Europe)

•             Asia-Pacific (Japan, China, India, Australia, South Korea, Rest          of Asia-Pacific)

•             LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA)

  Companies covered

Abcam, AMS Biotechnology, Aviva Systems Biology, Roche Diagnostics, Bio-Rad Laboratories, Scantibodies Laboratory, Rockland Immunochemicals, Sysmex Corporation, Meridian Bioscience and Thermo Fisher Scientific

 

COVID – 19 scenario analysis: 

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to immunoassay interference blocker has been reduced and this segment have to face negligence subsequently causing negative impact on immunoassay interference blocker market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Heavy investments in research and development activities related to immunoassay interference inhibitors with the motive of gaining accuracy in clinical diagnosis, to reduce the degree of errors for the results of biochemical analysis and advancement in blocker used for interference and kits manufacturing are the major drivers for growing immunoassay interference blocker market. The U.S. industry spend approximately 2-3% in research & development activities related to immunoassay interference inhibitors. Furthermore, constant clinical efforts and research studies emphasized on improvising diagnosis of various diseases and disorders in order to provide efficient treatment and care to patients, advancement in the new drug discoveries and diagnostics biologics further catalyzes the growth of this market. Laboratory diagnostic results, including immunoassay results, impact and lead about 70 percent of clinical healthcare decisions related to further treatment of the aliment. Inaccurate diagnostic results due to antibody interference increase the risk of irrelevant and sometimes irreversible treatment.

Rising focus of the major industry players on bringing new technologies and kits that could aid in effective diagnosis which would emphasize on progressive patterns of cancer and other chronic, viral and infectious diseases and better patient survival rate coupled with advances that aid in amplifying the capabilities of research and development to propel the immunoassay interference blocker market over the coming years.

Immunoassay interference prevalence depends on the endogenous substance interference type upon and the analyte and assay. However, implementation of inhibitor in the patient’s diagnostic sample fails to restrict full range of protein interference and hence cannot bolster on full accuracy of the results. This can have a negative impact on immunoassay interference locker market and impede the growth.

Increasing prevalence of chronic and viral diseases and healthcare expenditure to boost the growth

According to the statistics published by world health organization (WHO), there has been immense increase in chronic diseases worldwide. In 2001, chronic diseases accounted for almost 60% of the 56.5 million reported deaths with approximately 46% of the burden of disease worldwide. Non-communicable diseases (NCDs) are expected to increase upto 57% by 2020. The geriatric population is expected to rise by 22% by the year 2050, according to WHO. The number of infectious & non-infectious diseases has been rising simultaneously. According to the WHO, by 2018, the number of people infected with this virus is 75 million right from the beginning of this pandemic and around 32 million people have died because of this disease. Additionally, by the end of2018, around 37.9 million people were living with HIV. The growth in various diseases would ensure market development for this market.

Organization for Economic Co-operation and Development (OECD) survey report, stated in 2018 average per capita health expenditure in the U.S. was about USD 10,586. Thus, the rising healthcare expenditure would also contribute to the global immunoassay interference blocker market.

The efforts taken to increase the accuracy of diagnostic results, increasing incidences of chronic diseases and increasing healthcare expenditure are factors that would facilitate the market growth.

North American region dominates the market

North America is expected to lead the reprocessed medical devices market throughout. The dominance is due to factors like rise in the global prevalence of cardiovascular diseases and higher adoption of technology in the region. According to Centers for Disease Control and Prevention, cardiac diseases are a leading cause of death in American men. As per the American Heart Association, in 2018, nearly 92.1 million individuals in the U.S. suffered from cardiovascular diseases resulting higher demand for affordable treatment and cost effective therapies is propelling the market in the United States. Drastic rise in healthcare expenditure and high strain to get better health outputs at lower costs, availability of a well-developed infrastructure and presence of major industry are the other factors fostering the market in the near future.

Key segments:

Segments

Sub-segments

  Product type

  • Antibody interferences
  • Detection interferences
  • Surface interferences

  Application

  • Sandwich Immunoassays
  • Antibody Capture Assays
  • Competitive ELISA
  • Others

  End Users

  • Academic research institutes
  • Biotech and pharma companies
  • Molecular diagnostic companies
  • Diagnostic Test Laboratories
  • Other

  Region

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

 

Key benefits of the report:

  • This study presents the analytical depiction of the global immunoassay interference blocker industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global immunoassay interference blocker market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global immunoassay interference blocker market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global immunoassay interference blocker market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Immunoassay interference blocker Market research report:

  • What are the leading market players active in the immunoassay interference blocker market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 
PURCHASE OPTIONS

Start reading ,This title and over 12000 thousand more,available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

 
Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Immunoassay Interference Blocker Market: Global Opportunity Analysis and Industry Forecast, 2020-2027

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $8,995  $8,096
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading.
    This title and over 12,000+ are available on the Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers